FIELD: biotechnology.
SUBSTANCE: invention relates to production of recombinant protein containing sequences of myelo-peptides, and can be used for treatment of secondary immunodeficiencies. Recombinant protein (REC-MP) is constructed by alternation of short active myelopeptides MP-1 (FLGFPT), MP-2 (LVVYPW), MP-3 (LVCYPQ) and MP-4 (FRPRMTP), alternating with thrombin and urokinase recognition sites.
EFFECT: invention allows to increase clinical effectiveness of treatment of secondary immunodeficiencies by more evident stimulation of antibodies formation, by increasing the number of B-lymphocytes expressing CD25 and CD69 on their surface.
5 cl, 4 dwg, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PURIFICATION OF RECOMBINANT PROTEIN CONTAINING MYELOPEPTIDES SEQUENCES | 2016 |
|
RU2630302C1 |
APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
METHOD OF PRODUCING BIOLOGICALLY ACTIVE PEPTIDES | 2014 |
|
RU2601126C2 |
VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
OPTIMIZED RECOMBINANT PROTEIN ENCODING GENE - HUMAN INTERFERON BETA ANALOG | 2015 |
|
RU2614264C2 |
PEPTIDE-IMMUNOREGULATOR (VERSIONS), MEDICINAL AGENT COMPRISING PEPTIDE-IMMUNOREGULATOR | 1998 |
|
RU2198178C2 |
IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
DNA VACCINE AGAINST PROLIFERATING ENDOTHELIAL CELLS AND USES THEREOF | 2003 |
|
RU2318019C2 |
PHARMACEUTICAL COMPOSITION AND METHOD OF STIMULATING IMMUNE RESPONSE TO Mycobacterium avium SUBSPECIES Paratuberculosis | 2008 |
|
RU2489165C2 |
ACTIVE ANGIOGENESIS-PREVENTING IMMUNETHERAPY | 2003 |
|
RU2329824C2 |
Authors
Dates
2016-05-27—Published
2014-09-17—Filed